Robert Azelby
Officer, Director at Eliem Therapeutics, Inc. (CLYM)
Robert Azelby has filed 26 insider reports with the SEC since June 2021, as director at Cardinal Health Inc (CAH), director at Autolus Therapeutics plc (AUTL) and director at Tango Therapeutics, Inc. (TNGX) and at 5 more companies. Robert Azelby made no open-market purchases or sales in the last 12 months. The latest filing, on November 16, 2026, reports grant or award at Cardinal Health Inc (CAH).
- Filings
- 26
- Companies
- 8
- Bought on market
- None
- Sold on market
- $20.2K
Companies where Robert Azelby is an insider
| Company | Role | Shares held | Bought | Sold | Avg buy | Price now | Last filing |
|---|---|---|---|---|---|---|---|
| Directorsince March 2024 | 4,840 | $272.81 | Nov 16, 2026 | ||||
| Directorsince March 2026 | $0.9073 | Jul 1, 2026 | |||||
| Directorsince June 2026 | 5,740 | $21.73 | Jun 23, 2026 | ||||
| Directorsince January 2024 | 112,805 | $20.2K | $1.28 | Jun 3, 2026 | |||
| Directorsince February 2025 | May 5, 2026 | ||||||
| Directorsince April 2023 | Aug 11, 2023 | ||||||
| Officer, Director | $9.19 | Nov 2, 2022 | |||||
| Director | Jun 12, 2021 |
Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record.
Every filing
- Nov 12, 2026CAHDirector Azelby Robert was granted 755 shares, increasing direct ownership by 18% to 4,840 unitsForm 4Grant or award
- Jun 29, 2026AUTLSEC Form 4 filed by Director Azelby RobertForm 4Grant or award
- Jun 19, 2026TNGXDirector Azelby Robert was granted 5,740 sharesForm 4Grant or award
- Jun 19, 2026TNGXRobert Azelby became an insiderForm 3New insider
- Jun 3, 2026ADCTDirector Azelby Robert was granted 45,000 shares and covered exercise/tax liability with 12,600 shares, increasing direct ownership by 40% to 112,805 units to cover withholding taxForm 4Grant or awardShares withheld for taxes or exercise price
- May 5, 2026TERNSEC Form 4 filed by Director Azelby Robert to satisfy tax liabilityForm 4Sale back to the company
- Mar 18, 2026AUTLRobert Azelby became an insiderForm 3New insider
- Feb 1, 2026TERNSEC Form 4 filed by Director Azelby RobertForm 4Grant or award
- Nov 5, 2025CAHDirector Azelby Robert was granted 1,067 shares, increasing direct ownership by 35% to 4,085 unitsForm 4Grant or award
- Jun 13, 2025ADCTDirector Azelby Robert covered exercise/tax liability with 12,600 shares, decreasing direct ownership by 14% to 80,405 unitsForm 4Shares withheld for taxes or exercise price
- Jun 3, 2025ADCTDirector Azelby Robert was granted 40,000 shares, increasing direct ownership by 75% to 93,005 unitsForm 4Grant or award
- Feb 20, 2025TERNSEC Form 4 filed by Director Azelby RobertForm 4Grant or award
- Feb 20, 2025TERNRobert Azelby became an insiderForm 3New insider
- Nov 6, 2024CAHDirector Azelby Robert was granted 1,730 shares, increasing direct ownership by 134% to 3,018 unitsForm 4Grant or award
- Jun 17, 2024-$20.2KADCTDirector Azelby Robert sold $20,216 worth of shares (6,995 units at $2.89), decreasing direct ownership by 12% to 53,005 unitsForm 4Open-market sale
- Jun 17, 2024~$20.2KADCTRobert Azelby plans to sell 6,995 shares (~$20.2K)Form 144Planned sale
- Jun 13, 2024ADCTDirector Azelby Robert was granted 40,000 shares, increasing direct ownership by 200% to 60,000 unitsForm 4Grant or award
- Mar 15, 2024CAHAzelby Robert was granted 1,288 sharesForm 4Grant or award
- Mar 1, 2024CAHRobert Azelby became an insiderForm 3New insider
- Jan 2, 2024ADCTNew insider Azelby Robert claimed ownership of 20,000 sharesForm 3New insider
- Aug 11, 2023KDNYSEC Form 4 filed by Azelby RobertForm 4Sale back to the company
- Apr 10, 2023KDNYSEC Form 4 filed by Azelby RobertForm 4Grant or award
- Apr 10, 2023KDNYRobert Azelby became an insiderForm 3New insider
- Oct 31, 2022CLYMSEC Form 4 filed by Azelby RobertForm 4Grant or award
- Jan 27, 2022CLYMSEC Form 4 filed by Azelby RobertForm 4Grant or award
- Jun 10, 2021CLVSSEC Form 4 filed by Azelby RobertForm 4Grant or award
Compare Robert Azelby with
- Robert Azelby vs John B Ketchum1 shared
- Robert Azelby vs Akhil Johri1 shared
- Robert Azelby vs Robert W Musslewhite1 shared
- Robert Azelby vs Nancy Killefer1 shared
- Robert Azelby vs Christine Mundkur1 shared
- Robert Azelby vs Patricia Hemingway Hall1 shared
Other insiders at the same companies
- John B KetchumTNGX
- Sudhakar RamakrishnaCAH
- Patricia Hemingway HallCAH
- Nancy KilleferCAH
- Akhil JohriCAH
- Christine MundkurCAH
- Robert W MusslewhiteCAH
- Anita A ZielinskiCAH
- Sheri H. EdisonCAH
- David C EvansCAH
- Michelle BrennanCAH
- Adam CrystalTNGX
- Jessica NewcombTNGX
- Ra Capital Management, L.P.CLYM
- Stephen Basil ThomasCLYM
- Cintia PiccinaAUTL
Questions about Robert Azelby
- What is Robert Azelby's role at Eliem Therapeutics, Inc.?
- Robert Azelby reports to the SEC as officer and director at Eliem Therapeutics, Inc. (CLYM), according to the latest filing on November 2, 2022. Robert Azelby has also filed as director at Cardinal Health Inc (CAH), director at Autolus Therapeutics plc (AUTL), director at Tango Therapeutics, Inc. (TNGX) and director at ADC Therapeutics SA (ADCT).
- How many shares does Robert Azelby own?
- After the latest filing that states it, Robert Azelby directly owned 4,840 shares of Cardinal Health Inc (CAH), 5,740 shares of Tango Therapeutics, Inc. (TNGX) and 112,805 shares of ADC Therapeutics SA (ADCT). Shares held through trusts, funds or family members are reported separately and are not counted here.
- Has Robert Azelby bought or sold stock recently?
- The most recent open-market sale was on June 17, 2024: sold 6,995 shares of ADC Therapeutics SA (ADCT) for $20.2K at an average of $2.89.
- How do I get alerts when Robert Azelby files?
- Follow Robert Azelby on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale. Robert Azelby filed 1 time in the last 90 days.
From SEC Forms 3, 4, 5 and 144 filed by Robert Azelby (SEC CIK 0001656998). Totals count each trade once, skipping amendments whose original is on file, from Jun 12, 2021 on. View on SEC EDGAR · Get this as JSON